Literature DB >> 6335151

Antibody responses to capsular polysaccharide, lipopolysaccharide, and outer membrane in adults infected with Haemophilus influenzae type b.

T Lagergård, O Nylén, T Sandberg, B Trollfors.   

Abstract

The antibody response to Haemophilus influenzae type b antigens as capsular polysaccharide, lipopolysaccharide, and outer membrane components was studied by enzyme-linked immunosorbent assay in 10 adults infected with this bacterium. Almost all patients had detectable amounts of immunoglobulins G and M antibodies specific to capsular polysaccharide, lipopolysaccharide, or outer membrane in their first serum sample. A significant antibody response in one or more antibody subclasses to capsular polysaccharide, lipopolysaccharide, and outer membrane was noted in 9 of 10, 7 of 10, and 7 of 10 patients, respectively. The occurrence of H. influenzae type b infections in adults cannot be completely explained either by the absence of antibodies against H. influenzae type b in their serum or by the failure to develop specific antibodies to the capsule or certain cell wall components even if these factors probably are important in some cases, e.g., in one patient who was splenectomized.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6335151      PMCID: PMC271536          DOI: 10.1128/jcm.20.6.1154-1158.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

Review 1.  Haemophilus influenzae: immunology and immunoprotection.

Authors:  M Solotorovsky; M Lynn
Journal:  CRC Crit Rev Microbiol       Date:  1978-09

2.  Hemophilus influenzae pneumonia in adults.

Authors:  R J Wallace; D M Musher; R R Martin
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

3.  The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  H Käyhty; H Peltola; V Karanko; P H Mäkelä
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

4.  Hemophilus influenzae in hospitalized adults: current perspectives.

Authors:  H B Simon; F S Southwick; R C Moellering; E Sherman
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

5.  Meningitis and septicaemia due to haemophilus influenzae type b in pregnancy.

Authors:  T Sandberg; T Dahlberg
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-21

6.  Enzyme-linked immunosorbent assay for titration of Haemophilus influenzae capsular and O antigen antibodies.

Authors:  T Dahlberg; P Branefors
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

7.  Host defense against Streptococcus pneumoniae: the role of the spleen.

Authors:  D W Wara
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

8.  Haemophilus influenzae infections in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production.

Authors:  R J Wallace; D M Musher; E J Septimus; J E McGowan; F J Quinones; K Wiss; P H Vance; P A Trier
Journal:  J Infect Dis       Date:  1981-08       Impact factor: 5.226

9.  Human antibody responses to lipopolysaccharide after meningitis due to Haemophilus influenzae type b.

Authors:  J L Shenep; R S Munson; D M Granoff
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

10.  Bacteremic hemophilus influenzae pneumonia in adults. A report of 24 cases and a review of the literature.

Authors:  D C Levin; M I Schwarz; R A Matthay; F M LaForce
Journal:  Am J Med       Date:  1977-02       Impact factor: 4.965

View more
  2 in total

1.  Development of serum antibodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infections.

Authors:  B A Claesson; T Lagergård; B Trollfors
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

2.  Serum antibody response to capsular polysaccharide, outer membrane, and lipooligosaccharide in children with invasive Haemophilus influenzae type b infections.

Authors:  B A Claesson; T Lagergård; B Trollfors; L Gothefors; U Jodal
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.